This webcast features: Khaled S. Mriziq, PhD, Senior Marketing Manager, Process Chromatography, Bio-Rad Laboratories. In this webinar, we will present performance data for the newly launched, GMP ready CHT™ Ceramic Hydroxyapatite prepacked process-scale columns. This will include HETP and asymmetry data that shows excellent column performance and shipping stability over a range of column diameters. The columns are designed to eliminate any headspace formation during transportation. Cycling and pressure data will also be presented. Foresight Pro Columns can be used…
Monday, June 20, 2022 Daily Archives
Elektrofi bags $40m funding to establish manufacturing line
Elektrofi has received $40 million in a Series B financing round to fund a manufacturing line to support clinical trials and double its headcount. Elektrofi, a Boston-based biotech that focuses on drug formulation and delivery, says part of the $40 million will be used to establish a centralized manufacturing line to support numerous upcoming clinical trials. “This financing sets the stage for advancement of multiple lead programs to human trials, clinical validation of Elektrofi’s high concentration technology, and pipeline expansion…
Merck buying Seagen would make strategic sense, says analyst
Merck & Co. is eying up the acquisition of antibody-drug conjugate (ADC) Seagen, according to media reports. The Wall Street Journal reported late last week that Merck has been in talks regarding a potential acquisition of Seattle, Washington-headquartered Seagen for a while, though a deal is not expected to be imminent. However, such a deal “could make sense strategically,” according to SVB Securities analyst Andrew Berens. “We believe that there are synergies in the Seagen portfolio (three commercial assets and…
Batavia ups capacity at Netherlands plant
Batavia Biosciences will increase capacity for viral vectors and vaccine research and development at its plant in the Netherlands. Contract development manufacturing organization (CDMO) Batavia (acquired by CJ Cheiljedang in November 2021) will add 22,500 square feet at its Netherlands plant for an undisclosed fee. According to the CDMO, the expansion will enable it to increase its R&D activities for viral vector-based product development. This includes adeno-associated (AAV), lentivirus, adenovirus, and measles virus vectors. “At Batavia, we are reminded daily…
Entegris opens plant to address cold-chain supply challenges
The center in Billerica, Massachusetts will give clients the opportunity to test equipment and containers for freeze and thaw processes, says firm. According to Entegris, the facility will offer life sciences customers the chance to make use of the company’s knowledge surrounding cold-chain supply challenges. In turn, the firm says it can improve processes, decrease costs, and increase speed-to-market. Entegris is offering clients its Aramus Shaped 2D single-use bags with custom sizes, shapes, and assembly configurations as a part of…